Pegilated interferon alpha 2b «Pegaltevir» chronic hepatitis C treatment (randomized clinical trial)

Pegilated interferon alpha 2b «Pegaltevir» chronic hepatitis C treatment (randomized clinical trial)

Aim of investigation. Nowadays the question, whether pegylated interferon should be completely abandoned in the treatment of chronic hepatitis C (CHC) is still open. Beneficial interferon properties include: absence of mutagenic capacity for hepatitis C virus and drug interaction, stimulation of hos...

Full description

Saved in:
Bibliographic Details
Main Authors: Marina V. Mayevskaya, Ye. N. Bessonova, P. O. Bogomolov, N. I. Geyvandova, K. V. Zhdanov, V. G. Morozov, V. D. Pasechnikov, I. Yu. Khomenko, A. V. Yagoda, V. T. Ivashkin
Format: Article
Language:Russian
Published: Gastro LLC 2018-08-01
Series:Российский журнал гастроэнтерологии, гепатологии, колопроктологии
Subjects:
хронический гепатит с
лечение
исследуемый препарат пегальтевир®
препарат сравнения пегинтрон®
эффективность
безопасность
Online Access:https://www.gastro-j.ru/jour/article/view/97
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://www.gastro-j.ru/jour/article/view/97

Similar Items